DGAP-News: GLOBAL BIOENERGIES secures a 5.7 million euro grant to proceed with its second industrial pilot in Germany
(firmenpresse) - DGAP-News: Global Bioenergies S.A. / Key word(s): Miscellaneous
GLOBAL BIOENERGIES secures a 5.7 million euro grant to proceed with
its second industrial pilot in Germany
21.11.2013 / 08:30
---------------------------------------------------------------------
GLOBAL BIOENERGIES secures a 5.7 million euro grant to proceed with its
second industrial pilot in Germany
Evry (France) and Leuna (Germany) - November 21th, 2013 - Global
Bioenergies announces its decision to construct its second industrial pilot
on the site of the Leuna refinery, close to Leipzig in Germany. This new
pilot plant, to be supported by the German Federal Ministry of Education
and Research (BMBF) through a EUR 5.7 million grant, should include a 3
year study at the Fraunhofer Center for Chemical-Biotechnological Processes
(CBP). The pre-commercial pilot is designed for an isobutene production
capacity of up to 100 tons per year.
Global Bioenergies, a NYSE Alternext Paris listed company (ALGBE), is a
pioneer in the development of one-step fermentation processes for the
direct and cost-efficient transformation of renewable resources into light
olefins, the key building blocks of the petrochemical industry. The
Company's German subsidiary, Global Bioenergies GmbH, located in the
BIO-CITY building in Leipzig, has just been awarded a EUR 5.7 million grant
from the BMBF within the 'BioEconomy Cluster' framework.
'After conducting a systematic assessment of available pilot facilities in
North America and Europe, we have concluded that the Fraunhofer CBP
platform in Leuna offers the unique combination of fermentation
capabilities and olefin-oriented chemical engineering. Articulating our
process with the recognized German knowledge in chemical engineering will
be a key success factor', commented Marc Delcourt, CEO of Global
Bioenergies SA.
Gerd Unkelbach, Head of the Fraunhofer CBP, added: 'Historically focused on
petro-chemistry, the area around Leuna will benefit from new processes
based on renewable resources, such as the one from Global Bioenergies. The
CBP, inaugurated in October 2012 by Chancellor Angela Merkel, is the right
place to explore the technical and economic potential of this innovative
isobutene process.'
'With the support from the BMBF and the BioEconomy Cluster we can now focus
on building a European success story and taking part in the global
transition from fossil to renewable resources', added Thomas Buhl, Managing
Director of Global Bioenergies GmbH.
The pilot plant in Leuna will combine two 5,000 liter fermenters and a
complete purification system, mimicking all aspects of a commercial scale
plant. Designed for a production capacity of up to 100 tons per year, the
isobutene produced in Leuna can be used for the fabrication of plastics,
elastomers and fuels. Such scale will enable the delivery of samples to
industrialists. This second pilot is the final step in Global Bioenergies'
development program before the full scale exploitation of the isobutene
process.
In June 2013, Global Bioenergies had announced the launch of its first
industrial pilot in the heart of the Bazancourt-Pomacle biorefinery, close
to Reims. This first pilot, to be run through a collaboration with Arkema
and the CNRS, is supported by a EUR 5.2 million state financing through the
French 'Investissements d'Avenir' program. This first industrial pilot will
set the bases for large scale exploitation of the isobutene process in its
application to methacrylics.
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one
in Europe, that is developing a process to convert renewable resources into
hydrocarbons through fermentation. The Company initially focused its
efforts on the production of isobutene, one of the most important
petrochemical building blocks that can be converted into fuels, plastics,
organic glass and elastomers. Global Bioenergies continues to improve the
yield of its process and is actively entering the industrial pilot testing
phase. The company recently replicated this success to propylene and
butadiene and is also looking to continue with other members of the gaseous
olefins family, key molecules at the heart of petrochemical industry.
Global Bioenergies is listed on NYSE Alternext Paris (FR0011052257 -
ALGBE).
Should you like to be kept informed, subscribe to our news feed on
www.global-bioenergies.com
GLOBAL BIOENERGIES
Liliane Bronstein (France)
Tel: + 33 (0) 1 64 98 20 50
Email: invest(at)global-bioenergies.com
Thomas Buhl (Germany)
Tel: +49 (0) 89 740 041 60
Email: thomas.buhl(at)global-bioenergies.com
FRAUNHOFER CBP
Gerd Unkelbach
Tel: +49 (0) 3461 43 9101
Email: gerd.unkelbach(at)cbp.fraunhofer.de
PRESS CONTACT: Stockheim Media
Robert Mayer
Tel: +49 (0) 89 523 880 30
Email: gbe(at)stockheim-media.com
End of Corporate News
---------------------------------------------------------------------
21.11.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
240628 21.11.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
Datum: 21.11.2013 - 08:30 Uhr
Sprache: Deutsch
News-ID 318975
Anzahl Zeichen: 7481
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 300 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: GLOBAL BIOENERGIES secures a 5.7 million euro grant to proceed with its second industrial pilot in Germany"
steht unter der journalistisch-redaktionellen Verantwortung von
Global Bioenergies S.A. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).